Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
5.2
Journals
Cancers
Journal Awards
Best Paper Award
share announcement

Best Paper Award

Dear Colleagues,

We are pleased to announce the winners of the Cancers 2021 Best Paper Award. All papers published from 1 January 2021 to 31 December 2021 in Cancers were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, four winners were selected.

Two Reviews:
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
By Alessandro Rizzo et al.
Cancers 2021, 13(3), 558; doi: 10.3390/cancers13030558

STING Agonists as Cancer Therapeutics
By Afsaneh Amouzegar and Jason J. Luke et al.
Cancers 2021, 13(11), 2695; doi: 10.3390/cancers13112695

Two Articles:
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
By Christian Sordo-Bahamonde, Ana P. González-Rodríguez and Segundo Gonzalez et al.
Cancers 2021, 13(9), 2112; doi: 10.3390/cancers13092112

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
By Matteo Bauckneht et al.
Cancers 2021, 13(13), 3117; doi: 10.3390/cancers13133117

Each winner will receive CHF 500 and a chance to publish a paper free of charge in Cancers in 2023 after peer review.

Please join us in congratulating the winners of the Cancers 2021 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Cancers.

Kind regards,
Cancers Editorial Office

 
Cancers Best Paper Award
 
 
Past Winners
 
Year: 

Winner

13 pages, 632 KiB  
Review
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
by Alessandro Rizzo, Angela Dalia Ricci and Giovanni Brandi
Cancers 2021, 13(3), 558; https://doi.org/10.3390/cancers13030558 - 01 Feb 2021
24 pages, 790 KiB  
Review
STING Agonists as Cancer Therapeutics
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695 - 30 May 2021
16 pages, 4842 KiB  
Article
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto and Segundo Gonzalez
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112 - 27 Apr 2021
15 pages, 934 KiB  
Article
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
by Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi and Silvia Morbelli
Cancers 2021, 13(13), 3117; https://doi.org/10.3390/cancers13133117 - 22 Jun 2021

Winner

14 pages, 900 KiB  
Article
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
by Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Vineet Datta, Pradip Fulmali, Sachin Apurwa, Stefan Schuster, Ajay Srinivasan and Rajan Datar
Cancers 2022, 14(14), 3341; https://doi.org/10.3390/cancers14143341 - 09 Jul 2022
18 pages, 2344 KiB  
Article
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
by Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde and Daniel Sommermeyer
Cancers 2022, 14(8), 1998; https://doi.org/10.3390/cancers14081998 - 14 Apr 2022
27 pages, 12636 KiB  
Review
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627 - 26 Jan 2022
29 pages, 1779 KiB  
Review
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
by Yang Zhou, Miao Li, Kuangyi Zhou, James Brown, Tasha Tsao, Xinjian Cen, Tiffany Husman, Aarushi Bajpai, Zachary Spencer Dunn and Lili Yang
Cancers 2022, 14(9), 2266; https://doi.org/10.3390/cancers14092266 - 01 May 2022

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Prof. Donat Kögel
Klinikum der Goethe-Universität Frankfurt
Dr. Nicola Amodio
Università Magna Graecia di Catanzaro

Winner

John Maher
King’s College London, School of Cancer and Pharmaceutical Studies, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK https://www.mdpi.com/2072-6694/11/5/674
Barbara Wegiel
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA https://www.mdpi.com/2072-6694/11/4/450
Massimo Libra
Department of Biomedical and Biotechnological Sciences, Oncologic, Clinic and General Pathology Section, University of Catania, 95123 Catania, Italy https://www.mdpi.com/2072-6694/11/1/38
Anthony Gonçalves
Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France https://www.mdpi.com/2072-6694/11/7/1033

Award Committee

Dr. Samuel Mok Chairman
UT MD Anderson Cancer Center
Back to TopTop